`

Friday, 19 January 2018

Pharma/BioPharma News

  • Piramal Enterprises exploring to restart formulation business in India

    Pharma/BioPharma |  News | 0 Comment | 17 Jan, 2018

    Piramal Enterprises is assessing to come back in the domestic formulation market after a non-compete agreement with AbbottBSE 0.85 % expires this year. Piramal sold its domestic formulatio...Read more

  • Jubilant got approval for pesticide project

    Pharma/BioPharma |  News | 0 Comment | 15 Jan, 2018

    Jubilant Life Sciences has received a green nod for setting up a greenfield pesticide manufacturing unit at Bharuch, Gujarat at a cost of around Rs 250 crore, as per the official document.&...Read more

  • Lupin with Softovac enters the OTC segment

    Pharma/BioPharma |  News | 0 Comment | 15 Jan, 2018

    Lupin Limited (Lupin) has made a foray into the over-the counter (OTC) segment under the ‘Lupin Life Consumer Healthcare’ umbrella with the pan-India launch of Softovac. Softov...Read more

  • USFDA accepts NDA of Ortho Dermatologics for acne treatment

    Pharma/BioPharma |  News | 0 Comment | 15 Jan, 2018

    Ortho Dermatologics, a Valeant Pharmaceuticals International, Inc. company, is one of the largest prescription dermatology businesses in the world dedicated to helping patients in the treat...Read more

  • ISCR conference 2018: Collaborative clinical research for better patient outcomes

    Pharma/BioPharma |  News | 0 Comment | 10 Jan, 2018

    Collaborative Clinical Research for Better Patient Outcomes will be the theme of the 11th Annual Conference of the Indian Society for Clinical Research (ISCR) which will be held at JW Marri...Read more

  • Hetero introduces HumiraTM to treat rheumatoid arthritis in India

    Pharma/BioPharma |  News | 0 Comment | 03 Jan, 2018

    Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. The company has launc...Read more

  • Patent for Flu Vaccine granted in India

    Pharma/BioPharma |  News | 0 Comment | 03 Jan, 2018

    BiondVax is an advanced clinical stage biopharmaceutical company developing a universal flu vaccine. The company announced that one of its key patents titled "A Synthetic or Recombinant In...Read more

  • First generic cream Estrace lanunched by Mylan

    Pharma/BioPharma |  News | 0 Comment | 01 Jan, 2018

    Global pharmaceutical leader Mylan announced the U.S. launch of Estradiol Vaginal Cream USP, 0.01%, the first generic version of Allergan's Estrace® Cream.  Mylan received final a...Read more

  • Lupin’s generic psoriasis treatment approved by USFDA

    Pharma/BioPharma |  News | 0 Comment | 29 Dec, 2017

    Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top five pharmaceutical companies in India. Lupin is developing and delivering a wide r...Read more

  • Dr. Reddy's launched generic cancer injection

    Pharma/BioPharma |  News | 0 Comment | 26 Dec, 2017

    A therapeutic equivalent generic version of Alkeran (melphalan hydrochloride) for Injection is launched by Dr. Reddy’s laboratories in the United States market. The drug, which is us...Read more

  • To cut down imports India developing bulk drugs

    Pharma/BioPharma |  News | 0 Comment | 21 Dec, 2017

    India is the importer of drugs from China, now it’s time to reduce that import dependence we are in stage to evolve range of bulk drugs.  According to G N Singh, Drug Controller...Read more

  • Marken expands its presence in India

    Pharma/BioPharma |  News | 0 Comment | 19 Dec, 2017

    Marken made an announcement that it is going to open new branch in Ahmedabad and expand into larger spaces in Hyderabad and Delhi. Both offices will be operational in the first quarter, 20...Read more

  • Govt awards patent to Lincoln Pharma

    Pharma/BioPharma |  News | 0 Comment | 19 Dec, 2017

    Government has awarded a patent to Gujarat based Lincoln Pharmaceuticals for anti-malarial drug in India. The patent has been awarded for an Arteether injection to treat malaria. The drug ...Read more

  • Novo Nordisk and Torrent expand insulin facility

    Pharma/BioPharma |  News | 0 Comment | 12 Dec, 2017

    Novo Nordisk India and Torrent Pharmaceuticals recently announced the expansion of their insulin manufacturing facility at Torrent's Indrad factory. The facility was inaugurated by Peter T...Read more

  • Glenmark initiates myeloma drug trial

    Pharma/BioPharma |  News | 1 Comment | 08 Dec, 2017

    Glenmark Pharma has initiated the phase-1 clinical trial of GBR 1342, an investigational antibody for treatment of multiple myeloma. GBR 1342 is an investigational new drug from the compan...Read more

  • Mylan launches HepBest for chronic hepatitis B treatment

    Pharma/BioPharma |  News | 1 Comment | 07 Dec, 2017

    Mylan Pharmaceuticals Private Limited has launched HepBest 25 mg (tenofovir alafenamide, TAF), a once-daily tablet for the treatment of chronic hepatitis B in adults. According to Wor...Read more

  • US give nod to Biocon-Mylan's biosimilar of cancer drug Herceptin

    Pharma/BioPharma |  News | 0 Comment | 04 Dec, 2017

    The FDA said Mylan's drug Ogivri, which was co-developed with Biocon, was the first biosimilar approved in the United States to treat breast or stomach cancer. Herceptin and other complex ...Read more

  • Dr. Reddy’s achievement: Got first-cycle NDA approval of Impoyz cream

    Pharma/BioPharma |  News | 0 Comment | 01 Dec, 2017

    Dr. Reddy’s Laboratories Ltd., through its wholly owned subsidiary Promius Pharma, LLC, today announced its fifth consecutive, first-cycle NDA approval for the Proprietary Products Gr...Read more





Survey Box

Has Health Financing become an imperative need in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls